Selank Dosage: How Much to Take, When & How
Overview
Selank is a synthetic heptapeptide developed as an anxiolytic and nootropic agent, offering anxiety relief and cognitive support without the sedation or dependence risks of benzodiazepines. Unlike many other peptide compounds, Selank has established dosing protocols supported by clinical research, making it relatively straightforward to dose effectively.
This guide covers practical dosing information based on available clinical evidence, administration routes, cycling strategies, and cost considerations. Selank is available primarily through two administration routes: intranasal spray and subcutaneous/intramuscular injection, each with distinct dosing parameters.
Important Disclaimer: This content is educational and informational only. Selank is not approved for medical use in most Western countries and exists in a regulatory gray area. Consult a qualified healthcare provider before using Selank, particularly if you have underlying health conditions, take medications, or are pregnant or nursing.
Standard Dosing Protocol
The foundational dosing protocol for Selank follows these parameters:
Intranasal Administration:
- Dose Range: 250–500 mcg
- Frequency: Twice daily
- Total Daily Dose: 500–1,000 mcg
Injection (Subcutaneous or Intramuscular):
- Dose Range: 250–500 mcg
- Frequency: Once or twice daily
- Total Daily Dose: 250–1,000 mcg
Most users begin at the lower end of these ranges (250 mcg twice daily via nasal, or 250 mcg once daily via injection) and assess tolerance before increasing frequency or dose. The intranasal route is more commonly used for self-administration due to ease and non-invasiveness, though injection may offer more consistent absorption.
Dosing by Goal
While Selank's primary evidence supports anxiety and stress reduction, dosing varies slightly depending on your primary objective.
For Anxiety & Stress Management (Primary Use)
This is where Selank has the strongest clinical evidence. Studies showing pronounced anxiolytic effects used:
- Intranasal: 250–500 mcg twice daily (500–1,000 mcg/day total)
- Duration: 14 days to 4 weeks
- Expected Timeline: Anxiolytic benefits emerge within the first week; effects persist for approximately one week after discontinuation
Users targeting anxiety reduction typically maintain this standard protocol throughout their dosing cycle without escalation.
For Cognitive Enhancement & Nootropic Support (Secondary Use)
Selank demonstrates mild nootropic effects, particularly when combined with other compounds or during anxiety treatment. For cognition-focused use:
- Intranasal: 250 mcg twice daily (500 mcg/day total)
- Duration: 14–28 days
- Expectation: Mild cognitive benefits; more pronounced when baseline anxiety is reduced
Starting at the lower end (250 mcg twice daily) appears sufficient for nootropic purposes without escalating to higher doses.
For Stress Resilience & Adaptogenic Response
Selank's adaptogenic properties—including corticosterone regulation and microbiota support in animal models—suggest benefit for chronic stress:
- Intranasal: 250–500 mcg twice daily
- Duration: 21–28 days
- Approach: Consider higher frequencies (twice daily) for pronounced chronic stress; standard dosing is often adequate
For Sleep Optimization (Indirect Benefit)
Selank does not directly enhance sleep but may reduce benzodiazepine-induced sleep disturbances. If using Selank to improve sleep quality indirectly through anxiety reduction:
- Intranasal: 250 mcg, once in the morning and once in the early afternoon
- Timing: Avoid late-day dosing to prevent sedation interference with natural sleep
- Note: Mild sedation is a known side effect at higher doses; adjust timing accordingly
How to Administer
Intranasal Administration (Most Common)
- Preparation: Ensure nasal passages are clear. Use saline rinse 5–10 minutes prior if congested.
- Dosing: Draw the prescribed dose (typically 250–500 mcg in 20–50 µL solution) into the intranasal spray device or dropper.
- Application: Spray or apply dropwise into one nostril while slightly tilting the head back. Alternate nostrils with each dose to minimize irritation.
- Absorption: Allow 2–3 minutes for absorption before returning to normal activities.
- Side Effect Management: Mild nasal irritation or transient burning is common; this typically resolves within hours and decreases with repeated use.
Injection Administration (Subcutaneous or Intramuscular)
- Preparation: Selank for injection is typically supplied as a lyophilized powder requiring reconstitution or as a ready-to-inject solution. Follow manufacturer instructions for reconstitution (usually with sterile saline or bacteriostatic water).
- Dosing: Draw the prescribed dose (250–500 mcg) into a sterile insulin or tuberculin syringe.
- Site Selection:
- Subcutaneous: Upper arm, thigh, or abdomen (rotate sites)
- Intramuscular: Deltoid or gluteus maximus
- Injection: Insert the needle at a 90-degree angle (45 degrees for some subcutaneous sites), inject slowly, and withdraw the needle.
- Rotation: Change injection sites with each dose to prevent lipodystrophy or irritation.
Cycling & Timing
Recommended Cycling Protocol
Based on clinical study designs and safety data:
- Dosing Period: 14–28 days of consecutive daily dosing
- Common Cycle: 21 days on, 7–14 days off
- Restart: Resume dosing after the break period if continued benefit is desired
This cycling approach prevents potential tolerance development and allows assessment of whether continued use provides ongoing benefit.
Timing Within the Day